COVID-19 Updates
FDA/CDC
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
From the Journals
COVID-19: Experts call for ‘urgent’ global action to prevent suicide
An increase in suicide related to COVID-19 is not inevitable provided preventive action is prompt, the group notes.
News
COVID-19: What are the major cardiovascular issues?
COVID myocarditis can mimic acute MI or stress cardiomyopathy and will present diagnostic and therapeutic challenges.
Commentary
What will pediatrics look like in 2022?
Maybe you will have instituted an appointment schedule with sick visits in the morning and well checks in the afternoon.
Commentary
The cataclysmic COVID-19 pandemic: THIS CHANGES EVERYTHING!
One of the many lessons of this pandemic: Life as we know it should not be taken for granted, and can change drastically overnight.
From the Journals
Angiotensin drugs and COVID-19: More reassuring data
From the Journals
Hydroxychloroquine ineffective for COVID-19, VA study suggests
The retrospective study, which included
Feature
Prioritizing ambulatory gynecology care during COVID-19: The latest guidance
ACOG gives examples of which patients need in-person appointments, telehealth visits, or visits that should be deferred.
Latest News
European COVID-19 insights: Try helmet CPAP
An older, relatively inexpensive form of noninvasive ventilation appears to prevent self-induced lung injury.
Latest News
Are patients with epilepsy at increased risk of COVID-19 infection?
The COVID risk may not be elevated, but vigilance and caution are still warranted.
Latest News
COVID-19 antibody tests proliferate, but what do they show?
“Having many inaccurate tests is worse than having no tests at all,” one critic says.